Sustratos cromogénicos

Los sustratos cromogénicos son compuestos que producen un cambio de color visible cuando son metabolizados por enzimas específicas. Estos sustratos se utilizan ampliamente en ensayos diagnósticos, investigaciones bioquímicas y ensayos de inmunoabsorción enzimática (ELISA) para detectar y cuantificar la actividad enzimática. El cambio de color permite una identificación visual rápida y sencilla de las reacciones enzimáticas, lo que convierte a los sustratos cromogénicos en herramientas esenciales en el análisis de laboratorio. En CymitQuimica, ofrecemos una amplia selección de sustratos cromogénicos de alta calidad para apoyar sus aplicaciones de investigación y diagnóstico.

20
- 50
- 100
- 200

productos por página. Hay 790 productos en esta categoría.

Datos del producto	Pureza	Rango de precios	Entrega estimada
Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4672_P00CAS: 1254798-15-6	Min. 95 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside REF: 3D-B-7044	Min. 99.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4714_P00CAS: 2484873-15-4	Of Solute (Hplc) 98.0 To 100.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous REF: 3D-B-7398CAS: 129541-41-9	Min. 98.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4682_P00CAS: 2484872-49-1	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside REF: 3D-B-8932CAS: 212069-27-7	- - -	A consultar	Mar 10 Dic 24
Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4675_P00CAS: 2484872-47-9	Min. 95 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl butyrate REF: 3D-B-7050CAS: 129541-43-1	Min. 98.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4688_P00	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl myristate REF: 3D-B-7408CAS: 341972-95-0	Min. 98 Area-%	A consultar	Mar 10 Dic 24
Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4698_P00CAS: 2484872-58-2	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4678_P00CAS: 2484872-48-0	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl oleate REF: 3D-B-7412CAS: 341972-97-2	Min. 98 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl-α-D-N-acetylneuraminic acid, sodium salt REF: 3D-B-7040CAS: 160369-85-7	Min. 98.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 495 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4703_P00CAS: 2484872-62-8	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl-β-D-galactopyranoside REF: 3D-B-7150CAS: 7240-90-6	Min. 99.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-4-chloro-3-indoxyl-β-D-xylopyranoside REF: 3D-B-7750CAS: 207606-55-1	- - -	A consultar	Mar 10 Dic 24
Aldol® 484 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4696_P00CAS: 2484872-56-0	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
Aldol® 495 inositol-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4702_P00CAS: 2484872-61-7	Min. 95.0 Area-%	A consultar	Mar 10 Dic 24
5-Bromo-3-indoxyl phosphate, disodium salt REF: 3D-B-8912CAS: 16036-59-2	98.0 To 100.0 Area-%	A consultar	Mar 10 Dic 24

10mg		A consultar
25mg		A consultar
50mg		A consultar
100mg		A consultar
250mg		A consultar

Sustratos cromogénicos

Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4672_P00

5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside

Ref: 3D-B-7044

Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4714_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous

Ref: 3D-B-7398

Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4682_P00

6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside

Ref: 3D-B-8932

Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4675_P00

5-Bromo-4-chloro-3-indoxyl butyrate

Ref: 3D-B-7050

Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4688_P00

5-Bromo-4-chloro-3-indoxyl myristate

Ref: 3D-B-7408

Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4698_P00

Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4678_P00

5-Bromo-4-chloro-3-indoxyl oleate

Ref: 3D-B-7412

5-Bromo-4-chloro-3-indoxyl-α-D-N-acetylneuraminic acid, sodium salt

Ref: 3D-B-7040

Aldol® 495 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4703_P00

5-Bromo-4-chloro-3-indoxyl-β-D-galactopyranoside

Ref: 3D-B-7150

5-Bromo-4-chloro-3-indoxyl-β-D-xylopyranoside

Ref: 3D-B-7750

Aldol® 484 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4696_P00

Aldol® 495 inositol-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4702_P00

5-Bromo-3-indoxyl phosphate, disodium salt

Ref: 3D-B-8912